MTS Atlas
Built with+
SituationsCompaniesModelsInvestors
← All investors
KVKhosla Ventures logo

Firm & fund profile / Sourced portfolio

Khosla Ventures

Tracked participation in 17 Atlas companies, with 14 explicitly attributed leads.

Firm website ↗
17portfolio companies
33round participations
14lead positions
$2.1Bled round total
Conviction

Most recent leads

The latest rounds this investor is sourced as leading, newest first.

Jun 2026General IntuitionSeries A$320Mat $2.3B valuationApr 2026FactorySeries C$150Mat $1.5B valuationJan 2026WaabiSeries C$750MDec 2025PolyAISeries D$86Mat $750M valuationJul 2025Genesis AISeed (same $105M financing announcement republished)$105MJul 2025Genesis AISeed$105M
Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleLatest round
GIGeneral Intuition logoGeneral Intuition$6BJun 2026 → Aug 20262 rounds1 ledFundraising (reported talks / new investment round)
RRogo logoRogo$2B— → Apr 20264 rounds1 ledSeries D
FFactory logoFactory$1.5BApr 2026 → Apr 20261 round1 ledSeries C
WWaabi logoWaabi—Jun 2021 → Jan 20263 rounds3 ledSeries C
LLovable logoLovable$6.6BDec 2025 → Dec 20251 roundParticipantSeries B
PPolyAI logoPolyAI$750MSep 2021 → Dec 20254 rounds2 ledSeries D
SASakana AI logoSakana AI$2.7BJan 2024 → Nov 20253 rounds1 ledSeries B
FAField AI logoField AI$2BAug 2025 → Aug 20251 roundParticipantSeries A / Series A-1 (two consecutive rounds disclosed together)
MMoonvalley logoMoonvalley—Nov 2024 → Jul 20252 rounds1 ledSeries B (announced as additional $84M)
GAGenesis AI logoGenesis AI—Jul 2025 → Jul 20252 rounds2 ledSeed (same $105M financing announcement republished)
AAbridge logoAbridge—Jun 2025 → Jun 20251 roundParticipantSeries E
GGlean logoGlean$7.2BJun 2025 → Jun 20251 roundParticipantSeries F
RRegie.ai logoRegie.ai—Feb 2023 → Feb 20252 rounds1 ledSeries B
PIPhysical Intelligence logoPhysical Intelligence$2.4BMar 2024 → Nov 20242 roundsParticipantSeries A
NBNabla Bio logoNabla Bio—Dec 2021 → May 20242 rounds1 ledSeries A
RTRelation Therapeutics logoRelation Therapeutics—Mar 2024 → Mar 20241 roundParticipantSeed (new seed financing)
RReplit logoReplit$1.2BApr 2023 → Apr 20231 roundParticipantSeries B extension